atherothrombosis

Related by string. Atherothrombosis * * *

Related by context. All words. (Click for frequent words.) 70 atherothrombotic disease 69 atherosclerotic disease 69 atherothrombotic 68 HIV HCV coinfected 68 HeFH 68 variceal bleeding 68 microvascular disease 68 postoperative atrial fibrillation 67 antiphospholipid syndrome 67 dyslipidaemia 67 atherosclerotic cardiovascular 67 cardioembolic stroke 67 inflammatory rheumatic 67 intracranial hemorrhage ICH 67 PAOD 67 abnormal lipid 67 macrovascular events 67 chronic periodontitis 67 rheumatologic 67 primary hyperparathyroidism 66 de ath 66 Venous thromboembolism 66 thromboembolic disease 66 LV dysfunction 66 prostate cancer CaP 66 elevated triglyceride levels 66 multivessel disease 66 prospective multicenter study 66 nonalcoholic steatohepatitis 66 thromboembolic 66 arterial thrombotic 66 carotid atherosclerosis 66 thymectomy 66 carotid stenosis 66 ischemic vascular 66 acute coronary syndromes ACS 66 carotid plaques 66 postoperative AF 66 Diabetic nephropathy 66 diabetic kidney 66 etiologic 66 Erythropoietic therapies may 65 HER2 overexpression 65 Arrhythmias 65 subclinical atherosclerosis 65 chronic thromboembolic pulmonary 65 IPAH 65 thrombo embolic 65 patients undergoing CABG 65 angiographically 65 idiopathic pulmonary arterial hypertension 65 arterial calcification 65 carotid artery blockage 65 bronchogenic carcinoma 65 airway hyperresponsiveness 65 proliferative retinopathy 65 beta blockers ACE inhibitors 65 occlusive disease 65 thrombophilia 65 cytomegalovirus infection 65 intracerebral haemorrhage 65 ABCB1 65 Myelodysplastic syndromes MDS 65 bacterial prostatitis 65 Eisenmenger syndrome 65 NAFLD 65 Pulmonary arterial hypertension 65 AA Amyloidosis 65 cerebral vasospasm 65 ischemic cardiomyopathy 64 oesophageal adenocarcinoma 64 vWD 64 cirrhosis liver failure 64 diabetic microvascular complications 64 gallstone disease 64 nonalcoholic steatohepatitis NASH 64 malignant neoplasm 64 NOMID 64 relapsed MM 64 kidney urologic 64 nonischemic 64 T1DM 64 post thrombotic syndrome 64 adrenalectomy 64 gonococcal 64 pulmonary embolism PE 64 MYH9 64 stable angina 64 hepatorenal syndrome 64 familial hypercholesterolemia 64 Peripheral arterial disease 64 pyelonephritis 64 acute myocardial infarction MI 64 smoldering multiple myeloma 64 infective endocarditis 64 ADPKD 64 leiomyomas 64 Pulmonary hypertension 64 proliferative diabetic retinopathy 64 artery stenosis 64 macrovascular disease 64 systolic dysfunction 64 Aortic stenosis 64 atherogenic dyslipidemia 64 metastatic neuroendocrine tumors 64 SSc 64 pulmonary hypertension PH 64 smoldering myeloma 64 acute aortic dissection 64 Cardiotoxicity 64 silent ischemia 64 esophagogastric 64 valvular heart disease 64 diabetic retinopathy DR 64 basal cell carcinoma BCC 64 intracerebral hemorrhage ICH 64 FFR measurements 64 DVT PE 64 clinically heterogeneous 64 HER2 expression 64 venous thromboembolic disease 64 myocardial ischemia 64 thrombotic events 64 extracranial 63 coagulation abnormalities 63 unresectable tumors 63 tumor histology 63 stratifying patients 63 TTR amyloidosis 63 gastric adenocarcinoma 63 microbleeds 63 INTERHEART study 63 Sjögren syndrome 63 candidemia 63 lacunar 63 MGUS 63 basal cell nevus syndrome 63 hyperglycaemia 63 G6PD deficiency 63 nodal metastasis 63 Genetic variants 63 potentially modifiable 63 autonomic dysfunction 63 multicentric 63 diabetes mellitus DM 63 pretransplant 63 hyperphenylalaninemia HPA due 63 CHD CVD 63 thoracic aortic aneurysms 63 unstable angina pectoris 63 BPS IC 63 Chronic lymphocytic leukemia 63 abdominal adiposity 63 CMV infections 63 chronic myocardial ischemia 63 postoperative delirium 63 thrombocytopenic 63 PIGF 63 susceptibility loci 63 Diabetic neuropathy 63 T1c 63 onset diabetes mellitus 63 bifurcated lesions 63 bacteraemia 63 recurrent DVT 63 chlamydial infection 63 cardiac repolarization 63 cardiovascular disease hypertension 63 myeloproliferative neoplasms 63 APOL1 63 Nonalcoholic fatty liver 63 carotid plaque 63 Subarachnoid hemorrhage 63 myocardial infarction stroke 63 PROactive study 63 myocardial infarction MI 63 GPC5 63 vaso occlusive crisis 63 hypertension diabetes mellitus 63 histologic subtype 63 cardio renal 63 Heavy menstrual bleeding 63 left ventricular dysfunction 63 CYT# potent vascular disrupting 63 node metastases 63 neurologic complications 63 prostate carcinogenesis 63 Chronic Prostatitis 63 postoperative pulmonary 63 Clinicaltrials.gov 63 cerebrovascular accidents 63 Liver transplantation 63 Atherosclerotic 63 subclinical disease 63 Non Alcoholic Fatty 63 thromboembolism 63 Coronary artery calcification 63 unfavorable prognostic 63 elevated LDL cholesterol 63 non valvular atrial 63 polyarticular 63 nonmelanoma skin cancers 63 colorectal adenoma 63 thrombotic complications 63 LHRH receptor positive 62 valvular disease 62 microvascular complications 62 chorioamnionitis 62 serum phosphate 62 thromboembolic events 62 thromboembolic complications 62 transplantation HCT 62 intracerebral 62 patientswith 62 cardiac dysfunction 62 elevated ALT 62 portal vein thrombosis 62 Combination antiretroviral therapy 62 elevated uric acid 62 deep vein thromboses 62 riociguat 62 Endothelial dysfunction 62 liver transplant recipients 62 cystic fibrosis chronic pancreatitis 62 inflammatory biomarkers 62 vascular inflammation 62 hypercoagulable 62 pericardial effusion 62 transarterial 62 postoperative mortality 62 allogeneic HSCT 62 echocardiographic parameters 62 monogenic 62 rhythm disturbances 62 gastric carcinoma 62 genomic biomarker 62 lipohypertrophy 62 CRVO 62 underwent coronary angiography 62 abnormal lipids 62 stenoses 62 systemic lupus erythematosus 62 mixed hyperlipidemia 62 immunocompetent 62 T2DM 62 aortic insufficiency 62 carcinoid tumors 62 Hypercholesterolemia 62 muscular dystrophy cystic fibrosis 62 undergoing coronary angiography 62 thoracic aortic disease 62 overt nephropathy 62 AGGRASTAT ® tirofiban hydrochloride 62 co morbidities 62 Nonalcoholic Fatty Liver Disease 62 number NCT# ClinicalTrials.gov 62 arterial thrombosis 62 etiologic factors 62 BRCA1 BRCA2 62 aortic valve stenosis 62 haematologic 62 Akt inhibitor 62 revascularization procedures 62 ischemic complications 62 hematopoietic cancers 62 clevidipine 62 bridging fibrosis 62 fibrosis scarring 62 pelvic lymphadenectomy 62 KIF6 carriers 62 obesity insulin resistance 62 hyperparathyroidism 62 null responder 62 bicuspid aortic valves 62 NMIBC 62 uncontrolled hypertension 62 pulmonary artery banding 62 Prehypertension 62 revascularisation procedures 62 XIENCE V PROMUS Stent 62 BRCA mutation carriers 62 primary biliary cirrhosis 62 acute myocardial infarction AMI 62 Idiopathic pulmonary fibrosis 62 homozygous familial hypercholesterolemia 62 PsA 62 deep venous thromboses 62 Ischemic 62 osteosarcomas 62 elevated fasting glucose 62 retinal vascular 62 urolithiasis 62 SHPT 62 androgen excess 62 vascular dysfunction 62 macrovascular complications 62 gastric cardia 62 mutated K ras 62 liver transplantations 62 comorbid conditions 62 HBeAg negative 62 cerebral angiography 62 Afib 62 poor metabolizers 62 pancreatic adenocarcinoma 62 testicular germ cell 62 essential thrombocythemia 62 MYH9 gene 62 torsade de pointes 62 gastroenterology neurology 62 infarctions 62 arterial thickening 62 Renal Cell Carcinoma RCC 62 giant cell arteritis 62 intracranial stenosis 62 atherosclerotic lesions 62 coagulation disorders 62 cSSSIs 62 colorectal carcinoma 62 Lp PLA2 61 unstable angina UA 61 lipid lowering agents 61 demyelinating 61 juvenile idiopathic arthritis 61 oral antidiabetic medication 61 prolonged QT interval 61 percutaneous interventions 61 atrophic gastritis 61 upper gastrointestinal bleeding 61 left ventricular hypertrophy 61 recurrent glioblastoma multiforme 61 TEAEs 61 β blockers 61 pheochromocytoma 61 CMV infection 61 hypovitaminosis D 61 histological subtype 61 prognostic variables 61 LHON 61 asymptomatic carotid stenosis 61 Waldenstrom macroglobulinemia 61 Critical limb ischemia 61 Hp2 2 61 familial adenomatous polyposis 61 histologies 61 LQTS 61 noncardiovascular mortality 61 rebleeding 61 SORT OUT III 61 cholangiocarcinoma 61 minimally symptomatic 61 sonographic diagnosis 61 impaired glucose metabolism 61 myocardial ischaemia 61 hyperacute 61 histologically proven 61 preserved ejection fraction 61 atherosclerosis narrowing 61 nonobstructive CAD 61 retrospective cohort 61 lichen planus 61 ductal carcinomas 61 de novo lesions 61 obstructive coronary artery 61 undergoing CABG 61 CC genotype 61 coronary revascularization 61 hepatic cirrhosis 61 vasculopathy 61 Periodontal disease 61 transthyretin amyloidosis 61 chronic renal disease 61 PLX STROKE targeting 61 Acute Decompensated Heart Failure 61 clinicopathologic 61 intravenous bisphosphonates 61 lipid abnormalities 61 cryptogenic stroke 61 recurrent venous thromboembolism 61 Uncontrolled hypertension 61 hypercholesterolaemia 61 VCFS 61 dysglycemia 61 molecular biomarkers 61 hyperhomocysteinemia 61 Acute Coronary Syndromes ACS 61 malignant pleural mesothelioma 61 Neovascular AMD 61 intra abdominal abscess 61 clinicopathological 61 sCJD 61 atherosclerotic 61 thyrotropin levels 61 Hypertrophy 61 VTE 61 rheumatic disease 61 chromosome #p#.# 61 familial pancreatic cancer 61 pathologic fractures 61 morbidity mortality 61 circulating endothelial cells 61 hyperlipidaemia 61 invasive candidiasis 61 hereditary predisposition 61 Lung transplantation 61 Bronchiectasis 61 facial clefts 61 Pseudomonas aeruginosa infections 61 Prostatitis 61 Secondary efficacy endpoints 61 NIDDM 61 abnormal uterine bleeding 61 heavily pretreated 61 transplantation HSCT 61 KRAS oncogene 61 pancreatectomy 61 soluble CD# ligand 61 unknown etiology 61 carotid artery stenting CAS 61 cryptogenic 61 thromboses 61 Hepatocellular Carcinoma HCC 61 undergone radical prostatectomy 61 Exacerbations 61 coinfection 61 K ras mutations 61 liver metastasis 61 oropharyngeal 61 venous blood clots 61 nonfasting triglyceride levels 61 liver histology 61 VTE prophylaxis 61 visceral metastases 61 diabetic nephropathy 61 benign neoplasms 61 receiving VELCADE 61 hepatectomy 61 intracranial aneurysm 61 prothrombotic 61 VTEs 61 familial adenomatous polyposis FAP 61 genetic variants associated 61 ARVD 61 antiplatelet medications 61 comorbid depression 61 coronary revascularization procedures 61 histologically confirmed 61 Clostridium difficile infections 61 coexisting illnesses 61 spontaneous preterm birth 61 thromboprophylaxis 61 idiopathic pulmonary 61 Chronic HCV 61 Hypertriglyceridemia 61 genitourinary cancers 61 metabolic abnormalities 61 cardiovascular calcification 61 psychiatric comorbidities 61 neuroendocrine cancers 61 angioplasty stenting 61 CP CPPS 61 elevated CRP 61 carcinoid 61 clinico pathological 61 cardiometabolic disorders 61 papillary renal cell carcinoma 61 CTAP# Capsules 61 monoclonal gammopathy 61 squamous cell lung cancer 61 acute coronary syndromes 61 carotid IMT 61 neuropsychiatric diseases 61 ß blockers 61 antiphospholipid antibodies 61 infarction NSTEMI 61 lung metastasis 61 intracranial aneurysms 61 psoriatic arthritis PsA 61 Thromboembolic 61 familial hypercholesterolemia FH 61 chronic HBV infection 61 CTEPH 61 STRIDE PD 61 dilated cardiomyopathy DCM 61 multisystem disease 61 hemorrhagic complications 61 venous thrombosis 61 oral FTY# 61 cytogenic 61 AGGRASTAT R tirofiban hydrochloride 61 type2 diabetes 60 Lp PLA 2 60 metaplasia 60 Atypical Hemolytic Uremic Syndrome 60 postoperative complication 60 microvascular dysfunction 60 pulmonary artery hypertension 60 HSCT 60 myocardial infarction ventricular fibrillation 60 cerebral microbleeds 60 clefting 60 EGFR mutation status 60 cardio metabolic 60 symptomatic intracranial 60 perioperative complications 60 Brugada syndrome 60 amyloid deposition 60 thetreatment 60 multi factorial disease 60 hemodialysis patients 60 relapsed ALL 60 Ischemic stroke 60 lower extremity amputation 60 estimated glomerular filtration 60 S. aureus infection 60 recurrent miscarriage 60 coronary artery disease 60 posttransplant 60 revascularization procedure 60 graft occlusion 60 lymphoproliferative disorders 60 Adenomas 60 INCB# [003] 60 secondary hyperparathyroidism 60 Subgroup analyzes 60 thoracic aortic aneurysm 60 Mucositis 60 LRP5 60 postoperative infections 60 glycated hemoglobin levels 60 lymph node enlargement 60 diabetes dyslipidemia 60 Hypotension 60 fibrotic disease 60 chronicity 60 lymphomas leukemias 60 hypokalemia hypomagnesemia 60 arterial thromboembolic 60 computed tomography angiography 60 comorbid anxiety 60 colorectal adenomas 60 herpes zoster shingles 60 intrathoracic 60 Helicobacter pylori infection 60 myocardial infarctions 60 Systemic Lupus Erythematosus SLE 60 hyper IgE syndrome 60 paroxysmal atrial fibrillation 60 cortical dysplasia 60 atrial arrhythmias 60 coronary vascular 60 valvular heart 60 Inflammatory diseases 60 carotid bruit 60 abnormal glucose metabolism 60 circulating EPCs 60 Impaired glucose tolerance 60 recurrent glioblastoma multiforme GBM 60 polyp recurrence 60 trastuzumab Herceptin ® 60 CIMZIA TM certolizumab pegol 60 haematologic malignancies 60 intestinal metaplasia 60 multisystemic 60 asplenia 60 genetic determinants 60 cholestasis 60 gonococcal infection 60 hypercholesterolemia 60 Candida infection 60 erythropoietic 60 hypertension hypercholesterolemia 60 myeloperoxidase 60 metastatic bladder 60 immunosuppressant therapy 60 biliary tract cancer 60 presymptomatic 60 AAT deficiency 60 renal allograft 60 Plasmodium falciparum malaria 60 malperfusion 60 duplex ultrasonography 60 C. trachomatis 60 Coronary artery bypass graft 60 breast cancer subtypes 60 Coronary artery disease 60 microdeletions 60 debilitating complication 60 transfusion syndrome 60 elevated triglycerides 60 BMPR2 60 obstructive coronary 60 sJIA 60 UA NSTEMI 60 cardiovascular disease 60 intraoperative complications 60 myocardial infarct 60 gastroesophageal junction 60 haematological cancers 60 genotypic resistance 60 BEXXAR Therapeutic Regimen 60 novel VDA molecule 60 electrophysiologic 60 EGFR HER2 60 nonobstructive 60 Hypertrophic cardiomyopathy 60 narcolepsy cataplexy 60 cerebrovascular diseases 60 nontraumatic 60 atypical hyperplasia 60 fragility fractures 60 Myelodysplastic syndromes 60 pathophysiologic 60 diabetes mellitus hypertension 60 acadesine 60 adenomatous 60 intracerebral hemorrhage 60 coinfected patients 60 Coronary Artery Bypass Graft 60 thyrotoxicosis 60 renal artery stenosis 60 neurological complications 60 intracranial atherosclerosis 60 oncologic outcomes 60 nonvertebral fracture 60 immune dysregulation 60 metastatic gastric 60 corticosteroid induced 60 acute leukemias 60 NYHA Class II 60 cardiomyopathies 60 superficial femoral 60 Hashimoto thyroiditis 60 cardiac tamponade 60 cardiac biomarkers 60 antithrombotic 60 acute myocardial infarctions 60 proton MR spectroscopy 60 hypoperfusion 60 systemic amyloidosis 60 Genetic predisposition 60 Nonalcoholic Steatohepatitis 60 Torsades de Pointes 60 operable breast cancer 60 Cardio vascular 60 Left ventricular hypertrophy 60 tumor subtypes 60 paroxysmal AF 60 cerebral infarction 60 longitudinal cohort study 60 chronic myeloid 60 systemic autoimmune 60 renovascular hypertension 60 breast endometrial 60 anemia thrombocytopenia 60 AVAPRO 60 aortic atherosclerosis 60 gefitinib Iressa 60 myopathy rhabdomyolysis 60 dyslipidemia hypertension diabetes 60 EoE 60 metastatic malignant 60 Plaque buildup 60 lipid parameters 60 STK# gene 60 nonhereditary 60 chronic HCV infection 60 malignant lymphomas 60 cardio vascular disease 60 atherosclerotic coronary 60 supratentorial 60 lipid elevations 60 AML MDS 60 hepatologists 60 erythema nodosum 60 cardioembolic 60 Thrombolysis 60 colorectal liver metastases 60 neurologic symptoms 60 infrapopliteal 60 spontaneous regression 60 lipid lowering medications 60 hepatitis C HCV 60 comorbid illnesses 60 adenomatous polyps 60 cervicitis 60 heterotaxy 60 hematological parameters 60 gastroduodenal 60 ORMDL3 60 elevated IOP 60 Skin sterol 60 extrapyramidal symptoms 60 inducible nitric oxide synthase 60 spinal metastases 60 nonfatal myocardial infarction MI 60 nonmetastatic 60 underdiagnosis 60 decompensated heart failure 60 seropositivity 60 HF hospitalization 60 cMET 60 atherosclerotic progression 60 cutaneous melanoma 60 vascular abnormalities 60 Chronic pancreatitis 60 hypereosinophilic syndrome 60 relapsing remitting MS RRMS 60 XIENCE V demonstrated 60 sporadic ALS 60 hypercalciuria 60 suppurative 60 hepatocellular carcinoma HCC 60 breast abscesses 60 bronchial hyperresponsiveness 60 urothelial carcinoma 60 Sezary syndrome 60 acute coronary 60 IDDM 60 genetic loci 60 ANCA associated 60 GISTs 60 decompensated liver disease 60 prognostic markers 60 recurrent atrial fibrillation 60 serum lipid levels 60 idiopathic myelofibrosis 59 Diabetic Retinopathy 59 rFVIIa 59 Catheter Associated 59 embolizations 59 ragweed allergic 59 underwent resection 59 platelet reactivity 59 bowel resection 59 hepatic lesions 59 deCODE AF TM 59 tissue fibrosis 59 congenital malformations 59 ductal adenocarcinoma 59 Acute myeloid leukemia 59 coagulopathy 59 prospective multicentre 59 arterial thromboembolism 59 ADHF 59 oxidized phospholipids 59 paraneoplastic 59 systemic lupus erythematosus SLE 59 Thromboembolism 59 chronic hepatitis cirrhosis 59 myocardial infarction 59 ECG abnormalities 59 grade squamous intraepithelial 59 Ankylosing spondylitis 59 tachyarrhythmias 59 immunosuppression therapy 59 ALI ARDS 59 postoperative morbidity 59 functional mitral regurgitation 59 Chlamydia trachomatis infection 59 urine NGAL 59 glycosylated hemoglobin HbA1c 59 MYCN amplification 59 lower extremity amputations 59 Hyperparathyroidism 59 antihypertensive therapies 59 fluoroquinolone resistance 59 claudication 59 antiangiogenic therapy 59 acetabular dysplasia 59 Surgical resection 59 lipid lowering therapies 59 fibrosing 59 peripheral arterial occlusive disease 59 Relapsing remitting MS 59 cerebral vascular disease 59 androgen deficiency 59 arteriography 59 coronary lesions 59 antithrombotic therapy 59 epithelial ovarian 59 constipation OIC 59 endoleaks 59 TMP SMX 59 da mage 59 restenosis reblockage 59 clinically evaluable 59 symptomatic BPH 59 p# inhibitor 59 esophagus bladder 59 heterozygous FH 59 #q#.# [002] 59 LTBI 59 advanced adenomas 59 genetic syndromes 59 systolic hypertension 59 untreated OSA 59 von Willebrand 59 stem cell transplantations 59 lipid lowering drugs 59 vascular disease 59 hypoglycaemic episodes 59 cystoid macular edema 59 prospectively stratified 59 HIV coinfected 59 neointimal hyperplasia 59 abnormal glucose tolerance 59 angiotensin receptor blockers ARBs 59 periodontal infection 59 esophageal gastric 59 renal tumors 59 atherosclerosis 59 bladder augmentation 59 nonvascular 59 hepatic liver 59 vitreous floaters 59 G CSFs 59 systemic scleroderma 59 venous thromboembolism VTE 59 renal scarring 59 rheumatic diseases 59 imatinib resistance 59 recurrent coronary 59 revascularized 59 fibrosis progression 59 cartilage degeneration 59 infarcts 59 Darapladib 59 symptomatic VTE 59 ischemic strokes 59 VSMCs 59 SYNTAX trial 59 astrocytomas 59 juvenile idiopathic arthritis JIA 59 renal cell carcinomas 59 abacavir Ziagen 59 levodopa induced 59 nicardipine 59 liver resection 59 Autoimmune hepatitis 59 antiretroviral naïve 59 abnormal vaginal bleeding 59 endothelial activation 59 inotropic 59 hyperplastic 59 microscopic colitis 59 Naive Patients 59 hepatic steatosis 59 APOE genotype 59 APOE e4 allele 59 anterior uveitis 59 anti fibrotic 59 familial clustering 59 occlusion CRVO 59 hypercalcaemia 59 pacemaker implantation 59 coronary artery bypass grafts 59 LHRH antagonists 59 Evoltra ® 59 renal dysfunction 59 precancerous cervical 59 gastric atrophy 59 decompensated cirrhosis 59 limiting generalizability 59 embolic stroke 59 leukotriene pathway 59 NSAID induced 59 gastrointestinal stromal tumors GISTs 59 colorectal carcinogenesis 59 arterial insufficiency 59 antiretroviral naive 59 magnetic resonance CMR 59 granulomatous 59 heart arrhythmias 59 Cholesterol Levels SPARCL 59 endometrial hyperplasia 59 severe mitral regurgitation 59 mCRPC 59 PLMs 59 hyperkalemia 59 gestational hypertension 59 onset atrial fibrillation 59 Opportunistic infections 59 Deep venous thrombosis 59 darapladib 59 mitral regurgitation MR 59 plasma kallikrein 59 allogeneic hematopoietic stem cell 59 Alzheimer Disease AD 59 Pulmonary embolism 59 reinfarction 59 Beta thalassemia 59 protease inhibitors PIs 59 venous malformations 59 interstitial pneumonia 59 serum urate levels 59 Carotid 59 AT1R 59 mediastinitis 59 Chronic myeloid leukemia CML 59 Acute Coronary Syndromes 59 dyslipidemias 59 macroalbuminuria 59 cytogenetic abnormalities 59 neurocognitive impairment 59 lymphocyte counts 59 coronary stenosis 59 Alimentary Tract 59 glaucomatous 59 Postoperative complications 59 VEGF inhibitors 59 hemorrhagic strokes 59 IL 1ß 59 multicenter trials 59 NSTE ACS 59 diabetes hyperlipidemia 59 ventricular tachyarrhythmia 59 genitourinary tract 59 ocular disorders 59 HMG CoA reductase inhibitors 59 chronic GVHD 59 grade cervical dysplasia 59 parathyroid 59 stented vessel 59 amnestic MCI 59 angina myocardial infarction 59 advanced neoplasia 59 orally administered inhibitor 59 intima media thickness 59 VADT 59 renal denervation 59 prospectively enrolled 59 femoral neck fracture 59 fibrin deposition 59 CIN2 + 59 endophthalmitis 59 peritumoral brain edema 59 gastrointestinal perforation 59 Myocardial infarction 59 definite stent thrombosis 59 veno occlusive disease 59 diagnostic biomarker 59 2 diabetes T2D 59 varicella infection 59 antiarrhythmic drug 59 allogeneic bone marrow 59 atherosclerotic vascular disease 59 EBV infection 59 symptomatic carotid stenosis 59 Myocardial Infarction 59 primary aldosteronism 59 pathogenetic 59 IGFD 59 Severe Primary IGFD 59 ankylosing spondylitis AS 59 necrotic core 59 hematopoietic malignancies 59 Acute Myocardial Infarction AMI 59 Ischaemic heart 59 recurrent ischemic stroke 59 anticholinergic agents 59 vein thrombosis 59 Atherothrombosis 59 postoperative complications 59 tumor lysis syndrome 59 perioperative mortality 59 cutaneous lupus 59 adrenocortical cancer 59 CIMZIA ™ 59 coronary artery atherosclerosis 59 Uterine cancer 59 coronary insufficiency 59 plasma lipid 59 Bucindolol 59 endometriosis ovarian cysts 59 paraganglioma 59 calcium antagonists 59 post surgical adhesions 59 gait disturbance 59 SIADH 59 pelvic malignancies 59 Wisconsin Sleep Cohort 59 carcinomatosis 59 Tasigna prolongs 59 clinically detectable 59 neovascularisation 59 lymphangiogenesis 59 Henoch purpura 59 etiological 59 myeloproliferative disorders 59 carcinoids 59 gene rearrangements 59 renal cysts 59 Acute MI 59 intestinal polyps 59 cardiovascular disease CVD 59 multicenter Phase III 59 NATRECOR R 59 neovascular

Back to home page